CN118240856A - Escherichia coli toxic protein and its use and prokaryotic expression method - Google Patents

Escherichia coli toxic protein and its use and prokaryotic expression method Download PDF

Info

Publication number
CN118240856A
CN118240856A CN202410524229.9A CN202410524229A CN118240856A CN 118240856 A CN118240856 A CN 118240856A CN 202410524229 A CN202410524229 A CN 202410524229A CN 118240856 A CN118240856 A CN 118240856A
Authority
CN
China
Prior art keywords
hnh
coding frame
atpase
protein
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202410524229.9A
Other languages
Chinese (zh)
Inventor
杨泽婧
胡长江
范婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Second Affiliated Hospital Army Medical University
Original Assignee
Second Affiliated Hospital Army Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Second Affiliated Hospital Army Medical University filed Critical Second Affiliated Hospital Army Medical University
Priority to CN202410524229.9A priority Critical patent/CN118240856A/en
Publication of CN118240856A publication Critical patent/CN118240856A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

本发明提供了具有核酸内切酶活性的细胞毒性蛋白HNH的高效表达纯化方法,并证明了HNH的核酸内切酶活性。本发明的实施不仅优化了HNH的表达纯化方法,且提供了一种潜在的工具酶。

The present invention provides a highly efficient expression and purification method of a cytotoxic protein HNH having endonuclease activity, and proves the endonuclease activity of HNH. The implementation of the present invention not only optimizes the expression and purification method of HNH, but also provides a potential tool enzyme.

Description

一种大肠杆菌毒性蛋白及其用途和原核表达方法Escherichia coli toxic protein and its use and prokaryotic expression method

用技术领域Application technology

本发明涉及酶以及蛋白质表达纯化方法技术领域,尤其涉及具有内切酶活性的毒性蛋白HNH的表达纯化方法。The present invention relates to the technical field of enzyme and protein expression and purification methods, and in particular to an expression and purification method of a toxic protein HNH having endonuclease activity.

背景技术Background technique

HNH酶也称为“ββα-me”内切酶,该家族所有成员都具有高度相似的催化基序—ββα拓扑结构,该结构由30到40个氨基酸组成,负责核酸的结合和切割,结构特征为三个保守的氨基酸His-Asn-His残基(H-N-H)折叠成具有两个反向平行的β片层,一个α螺旋和一个结合二价金属阳离子的β-α-金属拓扑结构,最终折叠成ββα-金属拓扑结构。HNH enzymes are also called "ββα-me" endonucleases. All members of this family have a highly similar catalytic motif - a ββα topological structure, which consists of 30 to 40 amino acids and is responsible for the binding and cleavage of nucleic acids. The structural feature is that three conserved amino acid His-Asn-His residues (H-N-H) fold into a β-α-metal topological structure with two antiparallel β sheets, an α helix and a divalent metal cation binding, and finally folds into a ββα-metal topological structure.

HNH蛋白的序列保守性体现在位于β1链末端保守的His(对应HNH中的第一个字母“H”),金属离子与位于α-螺旋内的高度保守的Asn/His残基结合(对应HNH的最后一个字母“H”),位于β2链起始端的保守Asn(对应HNH中的字母“N”),高度保守的Asn通常与催化His旁边的主链原子形成氢键,从而在固定一般碱基的位置和取向方面起着重要的结构作用。HNH核酸酶作为单体发挥作用时,在核酸中制造单个缺口以降解外源或宿主基因组(Nickase内切酶),作为同源二聚体发挥作用时,引入双链DNA断裂以进行DNA限制、整合、重组和修复。The sequence conservation of HNH proteins is reflected in the conserved His at the end of the β1 chain (corresponding to the first letter "H" in HNH), the metal ion binding to the highly conserved Asn/His residue located in the α-helix (corresponding to the last letter "H" in HNH), the conserved Asn at the beginning of the β2 chain (corresponding to the letter "N" in HNH), and the highly conserved Asn usually forms hydrogen bonds with the main chain atoms next to the catalytic His, thus playing an important structural role in fixing the position and orientation of general bases. When HNH nucleases function as monomers, they create single nicks in nucleic acids to degrade foreign or host genomes (Nickase endonucleases), and when they function as homodimers, they introduce double-stranded DNA breaks for DNA restriction, integration, recombination, and repair.

前期研究表明,在原核表达HNH蛋白时,实验现象为大肠杆菌可以培养、但一经诱导表达,菌液逐渐变得清亮,初步推测HNH蛋白存在细胞毒性。因此建立一种不产生细胞毒性的表达纯化系统是提高HNH蛋白表达效率的关键。另外,HNH蛋白家族具有许多不同的序列,鉴定出新的具有内切酶活性的HNH蛋白也可进一步丰富工具酶的数量,为工具酶的改造和优化提供更多选择。Previous studies have shown that when the HNH protein is expressed in prokaryotes, the experimental phenomenon is that E. coli can be cultured, but once induced to express, the bacterial solution gradually becomes clear, and it is preliminarily speculated that the HNH protein is cytotoxic. Therefore, establishing an expression and purification system that does not produce cytotoxicity is the key to improving the expression efficiency of the HNH protein. In addition, the HNH protein family has many different sequences, and the identification of new HNH proteins with endonuclease activity can further enrich the number of tool enzymes and provide more options for the modification and optimization of tool enzymes.

发明内容Summary of the invention

针对现有技术存在的问题,本发明实施例提供了一种将HNH蛋白与同一开放阅读框内的ATPase蛋白共表达,并可获得可溶性目的HNH蛋白的方法。In view of the problems existing in the prior art, the embodiments of the present invention provide a method for co-expressing an HNH protein with an ATPase protein in the same open reading frame to obtain a soluble target HNH protein.

本发明首要目的在于提供一种HNH毒性蛋白表达载体,所述载体包含ATPase编码框和HNH编码框,且ATPase编码框和HNH编码框可同时独立表达。The primary purpose of the present invention is to provide an HNH toxic protein expression vector, wherein the vector comprises an ATPase coding frame and an HNH coding frame, and the ATPase coding frame and the HNH coding frame can be independently expressed simultaneously.

进一步地,所述HNH毒性蛋白表达载体为ATPase编码框和HNH编码框插入到任一原核表达载体内构成。Furthermore, the HNH toxic protein expression vector is composed of an ATPase coding frame and a HNH coding frame inserted into any prokaryotic expression vector.

进一步地,所述HNH毒性蛋白表达载体为ATPase编码框和HNH编码框插入到任一原核表达载体内的可表达ATPase编码框和HNH编码框的位置构成。Furthermore, the HNH toxic protein expression vector is composed of an ATPase coding frame and an HNH coding frame inserted into a position in any prokaryotic expression vector where the ATPase coding frame and the HNH coding frame can be expressed.

进一步地,所述ATPase编码框和HNH编码框均为来自大肠杆菌Retron-Eco4系统的ATPase编码框和HNH编码框。Furthermore, the ATPase coding frame and the HNH coding frame are both ATPase coding frame and HNH coding frame from the Escherichia coli Retron-Eco4 system.

进一步地,所述ATPase编码框和HNH编码框均为来自同一种细菌Retron-Eco4系统的ATPase编码框和HNH编码框。Furthermore, the ATPase coding frame and the HNH coding frame are both from the ATPase coding frame and the HNH coding frame of the Retron-Eco4 system of the same bacterium.

进一步地,所述ATPase编码框和HNH编码框均为来自同一株细菌Retron-Eco4系统的ATPase编码框和HNH编码框。Furthermore, the ATPase coding frame and the HNH coding frame are both from the ATPase coding frame and the HNH coding frame of the Retron-Eco4 system of the same bacterial strain.

进一步地,所述ATPase编码框编码的蛋白和HNH编码框编码的蛋白具有相互作用,且ATPase编码框编码的蛋白可抑制HNH编码框编码的蛋白的细胞毒性。Furthermore, the protein encoded by the ATPase coding frame and the protein encoded by the HNH coding frame interact with each other, and the protein encoded by the ATPase coding frame can inhibit the cytotoxicity of the protein encoded by the HNH coding frame.

进一步地,所述ATPase编码框编码的蛋白和HNH编码框编码的蛋白具有的相互作用不稳定或者结合力不强,在分子筛层析过程中二者会分离开来。Furthermore, the interaction between the protein encoded by the ATPase coding frame and the protein encoded by the HNH coding frame is unstable or the binding force is weak, and the two will be separated during the molecular sieve chromatography process.

在一个优选实施例中,ATPase编码框或HNH编码框连接一个标签蛋白编码框,所述标签蛋白编码框与ATPase编码框或HNH编码框一起表达出含有标签蛋白和ATPase或HNH的融合蛋白,所述标签蛋白位于ATPase编码框或HNH编码框的5’或3’端。In a preferred embodiment, the ATPase coding frame or the HNH coding frame is connected to a tag protein coding frame, and the tag protein coding frame and the ATPase coding frame or the HNH coding frame together express a fusion protein containing the tag protein and ATPase or HNH, and the tag protein is located at the 5' or 3' end of the ATPase coding frame or the HNH coding frame.

在一个优选实施例中,所述标签蛋白可以为6×His、FLAG或HA中的一种。In a preferred embodiment, the tag protein may be one of 6×His, FLAG or HA.

在一个优选实施例中,HNH编码框位于ATPase编码框的下游,二者之间含有间隔序列,所述间隔序列可使HNH编码框和ATPase编码框独立表达。In a preferred embodiment, the HNH coding frame is located downstream of the ATPase coding frame, and a spacer sequence is contained between the two, and the spacer sequence allows the HNH coding frame and the ATPase coding frame to be expressed independently.

在一个优选实施例中,所述HNH编码框、ATPase编码框、间隔序列以及标签蛋白编码框的形成如下结构:F-ATPase-B-HNH或ATPase-B-HNH-F,其中F为标签蛋白的编码框,B为间隔序列,优选的F为6×His,B为RBS(核糖体结合位点)。In a preferred embodiment, the HNH coding frame, ATPase coding frame, spacer sequence and tag protein coding frame form the following structure: F-ATPase-B-HNH or ATPase-B-HNH-F, wherein F is the coding frame of the tag protein, B is the spacer sequence, preferably F is 6×His, and B is RBS (ribosome binding site).

在一个优选实施例中,所述ATPase编码框编码如SEQ ID NO2.所示氨基酸序列,所述HNH编码框表达如SEQ ID NO1.所示氨基酸序列。In a preferred embodiment, the ATPase coding frame encodes the amino acid sequence shown in SEQ ID NO2., and the HNH coding frame expresses the amino acid sequence shown in SEQ ID NO1.

在一个优选实施例中,HNH毒性蛋白表达载体包含的HNH编码框、ATPase编码框、间隔序列以及标签蛋白编码框的结构如序列SEQ ID NO.3或SEQ ID NO.4所示,优选地为SEQID NO.3。In a preferred embodiment, the structure of the HNH coding frame, ATPase coding frame, spacer sequence and tag protein coding frame contained in the HNH toxic protein expression vector is as shown in the sequence SEQ ID NO.3 or SEQ ID NO.4, preferably SEQ ID NO.3.

在一个优选实施例中,上述序列插入在pCDFDuet载体第一个T7启动子后的BamHI/HindIII酶切位点之间。In a preferred embodiment, the above sequence is inserted between the BamHI/HindIII restriction sites after the first T7 promoter of the pCDFDuet vector.

一种HNH毒性蛋白表达纯化方法,所述方法包含以下步骤:A method for expressing and purifying a HNH toxic protein, the method comprising the following steps:

1)将HNH编码框、ATPase编码框在同一细胞内同时独立表达。1) The HNH coding frame and ATPase coding frame are expressed independently and simultaneously in the same cell.

2)表达产物初步纯化。2) Preliminary purification of the expression product.

3)初步纯化产物进行进一步纯化。3) The preliminary purified product is further purified.

在一个优选实施例中,步骤1)中HNH编码框、ATPase编码框在同一个载体中同时独立表达。In a preferred embodiment, in step 1), the HNH coding frame and the ATPase coding frame are independently expressed simultaneously in the same vector.

进一步地,步骤1)中所述ATPase编码框和HNH编码框均为来自大肠杆菌Retron-Eco4系统的ATPase编码框和HNH编码框。Furthermore, the ATPase coding frame and the HNH coding frame in step 1) are both ATPase coding frame and HNH coding frame from the Escherichia coli Retron-Eco4 system.

进一步地,步骤1)中所述ATPase编码框和HNH编码框均为来自同一种细菌Retron-Eco4系统的ATPase编码框和HNH编码框。Furthermore, the ATPase coding frame and the HNH coding frame in step 1) are both ATPase coding frame and HNH coding frame from the Retron-Eco4 system of the same bacterium.

进一步地,步骤1)中所述ATPase编码框和HNH编码框均为来自同一株细菌Retron-Eco4系统的ATPase编码框和HNH编码框。Furthermore, the ATPase coding frame and the HNH coding frame in step 1) are both ATPase coding frame and HNH coding frame from the Retron-Eco4 system of the same bacterial strain.

进一步地,步骤1)中所述ATPase编码框编码的蛋白和HNH编码框编码的蛋白具有相互作用,且ATPase编码框编码的蛋白可抑制HNH编码框编码的蛋白的细胞毒性。Furthermore, in step 1), the protein encoded by the ATPase coding frame and the protein encoded by the HNH coding frame interact with each other, and the protein encoded by the ATPase coding frame can inhibit the cytotoxicity of the protein encoded by the HNH coding frame.

进一步地,步骤1)中所述ATPase编码框编码的蛋白和HNH编码框编码的蛋白具有的相互作用不稳定或者结合力不强,在分子筛层析过程中二者会分离开来。Furthermore, in step 1), the interaction between the protein encoded by the ATPase coding frame and the protein encoded by the HNH coding frame is unstable or the binding force is weak, and the two will be separated during the molecular sieve chromatography process.

进一步地,步骤1)中ATPase编码框或HNH编码框连接一个标签蛋白编码框,所述标签蛋白编码框与ATPase编码框或HNH编码框一起表达出含有标签蛋白和ATPase或HNH的融合蛋白,所述标签蛋白位于ATPase编码框的5’或3’端。Furthermore, in step 1), the ATPase coding frame or the HNH coding frame is connected to a tag protein coding frame, and the tag protein coding frame and the ATPase coding frame or the HNH coding frame together express a fusion protein containing the tag protein and ATPase or HNH, and the tag protein is located at the 5' or 3' end of the ATPase coding frame.

在一个优选实施例中,所述标签蛋白可以为6×His、FLAG或HA中的一种。In a preferred embodiment, the tag protein may be one of 6×His, FLAG or HA.

在一个优选实施例中,HNH编码框位于ATPase编码框的下游,二者之间含有间隔序列,所述间隔序列可使HNH编码框和ATPase编码框独立表达。In a preferred embodiment, the HNH coding frame is located downstream of the ATPase coding frame, and a spacer sequence is contained between the two, and the spacer sequence allows the HNH coding frame and the ATPase coding frame to be expressed independently.

在一个优选实施例中,所述HNH编码框、ATPase编码框、间隔序列以及标签蛋白编码框的形成如下结构:F-ATPase-B-HNH或ATPase-B-HNH-F,其中F为标签蛋白的编码框,B为间隔序列,优选的F为6×His,B为RBS(核糖体结合位点)。In a preferred embodiment, the HNH coding frame, ATPase coding frame, spacer sequence and tag protein coding frame form the following structure: F-ATPase-B-HNH or ATPase-B-HNH-F, wherein F is the coding frame of the tag protein, B is the spacer sequence, preferably F is 6×His, and B is RBS (ribosome binding site).

在一个优选实施例中,所述ATPase编码框编码如SEQ ID NO2.所示氨基酸序列,所述HNH编码框表达如SEQ ID NO1.所示氨基酸序列。In a preferred embodiment, the ATPase coding frame encodes the amino acid sequence shown in SEQ ID NO2., and the HNH coding frame expresses the amino acid sequence shown in SEQ ID NO1.

在一个优选实施例中,HNH毒性蛋白表达载体包含的HNH编码框、ATPase编码框、间隔序列以及标签蛋白编码框的结构如序列SEQ ID NO.3或SEQ ID NO.4所示,优选地为SEQID NO.3。In a preferred embodiment, the structure of the HNH coding frame, ATPase coding frame, spacer sequence and tag protein coding frame contained in the HNH toxic protein expression vector is as shown in the sequence SEQ ID NO.3 or SEQ ID NO.4, preferably SEQ ID NO.3.

在一个优选实施例中,上述序列插入在pCDFDuet载体第一个T7启动子后的BamHI/HindIII酶切位点之间。In a preferred embodiment, the above sequence is inserted between the BamHI/HindIII restriction sites after the first T7 promoter of the pCDFDuet vector.

在一个优选实施例中,步骤3)利用凝胶过滤层析进行纯化。In a preferred embodiment, step 3) is purified by gel filtration chromatography.

一种内切酶,所述内切酶的序列含有如序列SEQ ID NO.1所示的氨基酸序列。A restriction endonuclease, the sequence of which contains the amino acid sequence shown in SEQ ID NO.1.

一个优选实施例中,所述内切酶的序列为SEQ ID NO.1所示的氨基酸序列。In a preferred embodiment, the sequence of the endonuclease is the amino acid sequence shown in SEQ ID NO.1.

进一步地,所述内切酶具有切割单链DNA的切口酶活性(nickase activity)。Furthermore, the endonuclease has nickase activity for cutting single-stranded DNA.

本发明具有以下有益效果:The present invention has the following beneficial effects:

1、提供了一种新的毒性蛋白表达纯化的载体和纯化方法,提高了毒性蛋白的表达效率。1. A new vector and purification method for the expression and purification of toxic proteins are provided, which improves the expression efficiency of toxic proteins.

2、提供了一种新的具有切割单链DNA的切口酶活性(nickase activity)的酶。2. Provides a new enzyme with nickase activity for cutting single-stranded DNA.

附图说明BRIEF DESCRIPTION OF THE DRAWINGS

下面结合附图和具体实施方式,对本发明的方法及其有益效果进行详细说明。The method of the present invention and its beneficial effects are described in detail below in conjunction with the accompanying drawings and specific embodiments.

图1:构建细胞毒性实验所需表达质粒。Figure 1: Construction of expression plasmids required for cytotoxicity experiments.

图2:细胞毒性实验结果。从上至下细菌浓度值逐渐下降,显示的图像为三次重复实验里的代表图。(A)HNH存在细胞毒性;(B)ATPase抑制HNH细胞毒性。Figure 2: Cytotoxicity test results. The bacterial concentration values decrease from top to bottom, and the images shown are representative images of three repeated experiments. (A) HNH is cytotoxic; (B) ATPase inhibits HNH cytotoxicity.

图3:ATPase与HNH的Co-IP实验结果。(A)ATPase-FLAG与HNH-HA共表达SDS-PAGE检测结果;(B)ATPase-FLAG与HNH-HA Western blot结果。Figure 3: Co-IP experimental results of ATPase and HNH. (A) SDS-PAGE detection results of co-expression of ATPase-FLAG and HNH-HA; (B) Western blot results of ATPase-FLAG and HNH-HA.

图4.ATPase和HNH共表达质粒构建。Fig. 4. Construction of ATPase and HNH co-expression plasmid.

图5:ATPase与HNH共表达结果。(A)标签带在HNH上的共表达镍亲和层析SDS-PAGE结果;(B)标签带在ATPase上的共表达镍亲和层析SDS-PAGE结果;(C)ATPase与HNH共表达产物Superdex200凝胶过滤层析纯化结果。Figure 5: Results of co-expression of ATPase and HNH. (A) Nickel affinity chromatography SDS-PAGE results of co-expression of the tag band on HNH; (B) Nickel affinity chromatography SDS-PAGE results of co-expression of the tag band on ATPase; (C) Superdex200 gel filtration chromatography purification results of the co-expression product of ATPase and HNH.

图6:HNH内切酶活结果。(A)100nM HNH蛋白存在Nickase酶活;(B)不同二价阳离子对HNH酶活的影响;(C)不同核苷酸对HNH酶活的影响;(D)内切酶实验示意图。Figure 6: HNH endonuclease activity results. (A) Nickase activity in the presence of 100 nM HNH protein; (B) Effects of different divalent cations on HNH activity; (C) Effects of different nucleotides on HNH activity; (D) Schematic diagram of endonuclease assay.

图7:加入IPTG诱导表达,菌液变化。左侧离心管中加入0.2mM IPTG诱导1h后的细菌变得澄清,右侧未诱导菌1h后仍然浑浊。Figure 7: Changes in bacterial solution after adding IPTG to induce expression. The bacteria in the centrifuge tube on the left became clear after 1 hour of induction with 0.2 mM IPTG, while the uninduced bacteria on the right remained turbid after 1 hour.

具体实施方式Detailed ways

下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。除非另有定义,本说明书所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本说明书中在本发明的说明书中所使用的术语只是为了描述具体的实施方式的目的,不是用于限制本发明。下述实施例中的实验方法,如无特殊说明,均为常规方法。下述实施例中的实验材料,如无特殊说明,均为自常规生化试剂商店购买得到的。The technical scheme in the embodiment of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiment of the present invention. Obviously, the described embodiment is only a part of the embodiment of the present invention, rather than all the embodiments. Based on the embodiments in the present invention, all other embodiments obtained by those skilled in the art without making creative work are within the scope of protection of the present invention. Unless otherwise defined, all technical and scientific terms used in this specification have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used in the specification of the present invention in this specification are only for the purpose of describing specific embodiments and are not used to limit the present invention. The experimental methods in the following embodiments are conventional methods unless otherwise specified. The experimental materials in the following embodiments are purchased from conventional biochemical reagent stores unless otherwise specified.

实施例中所述HNH蛋白和ATPase蛋白的氨基酸序列分别对应SEQ ID NO.1和SEQID NO.2。The amino acid sequences of the HNH protein and ATPase protein described in the examples correspond to SEQ ID NO.1 and SEQ ID NO.2, respectively.

SEQ ID NO.1(HNH):SEQ ID NO.1 (HNH):

MILKRINKTAEDQFLINFKAQNPNGTWDEFRNHEQGILYKRLKQHICNDQMYLCAYCEIDLDRENEHEIKVEHFKSKSGMILKRINKTAEDQFLINFKAQNPNGTWDEFRNHEQGILYKRLKQHICNDQMYLCAYCEIDLDRENEHEIKVEHFKSKSG

SLPGGSNWHLEWSNLLAVCLGGTNTGDDFELPANLSCDSYKSHYEDKNKINDKDWTGKILLPLTLPDAHNFFTFEKVTGSLPGGSNWHLEWSNLLAVCLGGTNTGDDFELPANLSCDSYKSHYEDKNKINDKDWTGKILLPLTLPDAHNFFTFEKVTG

KLLPNESYCNTISIDGKPAAETLSIVTKTIEVLNLNCSRLNNARRKLLFHFNNCARERNLRKLHNLLLQWNQGEPKFFQKLLPNESYCNTISIDGKPAAETLSIVTKTIEVLNLNCSRLNNARRKLLFHFNNCARERNLRKLHNLLLQWNQGEPKFFQ

TTRDIIIRDDRICQGLLNGTIRYYPYDVPDYATTRDIIIRDDRICQGLLNGTIRYYPYDVPDYA

SEQ ID NO.2(ATPase):SEQ ID NO.2 (ATPase):

MEQNLPSRITKLIKKSESGDFASSYQLYKVFGSKEYGVEPDEKMSDYFKELSAKQLEGGQLRVADIHLENYKGFESLIMMEQNLPSRITKLIKKSESGDFASSYQLYKVFGSKEYGVEPDEKMSDYFKELSAKQLEGGQLRVADIHLENYKGFESLIM

DFSMKKNSTILVGNNGCGKSTILDAIQKGLTHLSSRLSTRSHNGDGIEKHELRKGQNYASIAINYDYMGIRFPMIIATTDFSMKKNSTILVGNNGCGKSTILDAIQKGLTHLSSRLSTRSHNGDGIEKHELRKGQNYASIAINYDYMGIRFPMIIATT

EPGYEDRAKSNYSGINELGSIFKTAHSINPNVSFPLIAMYTVERANDVSTRDIENSEEIKEAQIWDKFKAYNKSLTGKAEPGYEDRAKSNYSGINELGSIFKTAHSINPNVSFPLIAMYTVERANDVSTRDIENSEEIKEAQIWDKFKAYNKSLTGKA

DFKLFFRWFKELIEIENSDNADITALRAEIRAKEKDLDNPLLKALLAENKNSETTKKLLEDHQNSLKVLKEKLNSYYSVDFKLFFRWFKELIEIENSDNADITALRAEIRAKEKDLDNPLLKALLAENKNSETTKKLLEDHQNSLKVLKEKLNSYYSV

NSKTLHTVEDAMYSFLPGFSNLKLQRAPLDLIVDKNNVSLSVLQLSQGEKTILALIADIARRLTLLNPNSVNPLDGTGINSKTLHTVEDAMYSFLPGFSNLKLQRAPLDLIVDKNNVSLSVLQLSQGEKTILALIADIARRLTLLNPNSVNPLDGTGI

VLIDEIDLHLHPSWQQNIIPRLEKTFKNIQFIVTTHSPQVCHTIDSQNIWLLKNGQKFKAPKGVRGAISSWVLENLFEVVLIDEIDLHLHPSWQQNIIPRLEKTFKNIQFIVTTHSPQVCHTIDSQNIWLLKNGQKFKAPKGVRGAISSWVLENLFEV

AQRPPEDKYTKLLQEYKNLVFSEKYASEDARKLGATLSQHFGPDDETLVELKLEIEKRIWEDDFEKDQDYKDDDDKSEQ ID NO.3(6XHis-ATPase-RBS-HNH):AQRPPEDKYTKLLQEYKNLVFSEKYASEDARKLGATLSQHFGPDDETLVELKLEIEKRIWEDDFEKDQDYKDDDDKSEQ ID NO.3 (6XHis-ATPase-RBS-HNH):

catcatcatcatcatcacagcggcgaaaacctgtattttcagggcgctagcGGATCCATGGAACAGAACTTACCGAGTAcatcatcatcatcatcacagcggcgaaaacctgtattttcagggcgctagcGGATCCATGGAACAGAACTTACCGAGTA

GAATAACTAAATTAATTAAAAAATCGGAAAGCGGCGATTTTGCTTCTTCGTATCAGCTTTATAAAGTATTTGGCTCGAAGAATAACTAAATTAATTAAAAAATCGGAAAGCGGCGATTTTGCTTCTTCGTATCAGCTTTATAAAGTATTTGGCTCGAA

AGAGTACGGAGTTGAGCCAGATGAAAAAATGTCTGATTACTTCAAAGAATTATCAGCTAAACAGTTAGAAGGTGGTCAAAGAGTACGGAGTTGAGCCAGATGAAAAAATGTCTGATTACTTCAAAGAATTATCAGCTAAACAGTTAGAAGGTGGTCAA

CTGAGAGTTGCTGATATTCATTTGGAAAACTACAAAGGGTTTGAGTCCCTAATAATGGATTTTTCCATGAAAAAAAACTCTGAGAGTTGCTGATATTCATTTGGAAAACTACAAAGGGTTTGAGTCCCTAATAATGGATTTTTCCATGAAAAAAAACT

CTACAATTTTAGTAGGAAATAATGGCTGTGGGAAAtcgacGATTCTCGATGCAATCCAGAAGGGGTTAACACATCTATCCTACAATTTTAGTAGGAAATAATGGCTGTGGGAAAtcgacGATTCTCGATGCAATCCAGAAGGGGTTAACACATCTATC

CTCGAGATTATCTACTCGCTCGCATAATGGCGATGGTATCGAAAAACATGAGTTAAGAAAAGGACAAAACTATGCATCGCTCGAGATTATCTACTCGCTCGCATAATGGCGATGGTATCGAAAAACATGAGTTAAGAAAAGGACAAAACTATGCATCG

ATCGCTATAAATTACGACTATATGGGAATACGTTTTCCTATGATCATAGCTACAACTGAACCTGGTTATGAGGATAGAGATCGCTATAAATTACGACTATATGGGAATACGTTTTCCTATGATCATAGCTACAACTGAACCTGGTTATGAGGATAGAG

CAAAAAGTAACTATAGCGGTATTAATGAGTTAGGAAGCATTTTCAAAACAGCCCATTCAATCAATCCAAATGTTTCATTCAAAAAGTAACTATAGCGGTATTAATGAGTTAGGAAGCATTTTCAAAACAGCCCATTCAATCAATCCAAATGTTTCATT

TCCTTTAATTGCAATGTATACAGTTGAAAGGGCTAATGACGTTTCTACTAGAGATATTGAAaattcAGAAGAAATTAAATCCTTTAATTGCAATGTATACAGTTGAAAGGGCTAATGACGTTTCTACTAGAGATATTGAAaattcAGAAGAAATTAAA

GAAGCTCAAATCTGGGATAAATTCAAAGCATATAATAAGAGCCTGACAGGAAAGGCTGATTTCAAATTATTCTTCAGATGAAGCTCAAATCTGGGATAAATTCAAAGCATATAATAAGAGCCTGACAGGAAAGGCTGATTTCAAATTATTCTTCAGAT

GGTTTAAAGAACTAATAGAAATCGAAAACTCTGATAACGCTGATATAACAGCATTAAGAGCAGAGATTCGTGCTAAAGAGGTTTAAAGAACTAATAGAAATCGAAAACTCTGATAACGCTGATATAACAGCATTAAGAGCAGAGATTCGTGCTAAAGA

AAAAGACTTAGACAATCCATTGCTAAAAGCTCTTCTGGCAGAGAATAAAAATTCTGAGACTACTAAAAAATTGTTAGAAAAAAGACTTAGACAATCCATTGCTAAAAGCTCTTCTGGCAGAGAATAAAAATTCTGAGACTACTAAAAAATTGTTAGAA

GATCATCAGAACTCTCTGAAAGTTTTAAAAGAGAAATTAAATAGCTATTATTCAGTCAATAGTAAAACATTACACACTGGATCATCAGAACTCTCTGAAAGTTTTAAAAGAGAAATTAAATAGCTATTATTCAGTCAATAGTAAAACATTACACACTG

TTGAAGATGCAATGTATTCTTTCCTTCCTGGTTTTAGCAACCTTAAACTTCAAAGGGCGCCTCTTGATCTGATAGTGGATTGAAGATGCAATGTATTCTTTCCTTCCTGGTTTTAGCAACCTTAAACTTCAAAGGGCGCCTCTTGATCTGATAGTGGA

TAAGAATAATGTTTCCTTAAGTGTTCTGCAATTATCTCAAGGTGAAAAAACCATTTTAGCATTAATTGCAGATATTGCTTAAGAATAATGTTTCCTTAAGTGTTCTGCAATTATCTCAAGGTGAAAAAACCATTTTAGCATTAATTGCAGATATTGCT

CGTAGATTGACATTGTTAAACCCTAATAGTGTTAACCCTTTGGACGGTACTGGAATTGTATTAATCGATGAAATAGACCCGTAGATTGACATTGTTAAACCCTAATAGTGTTAACCCTTTGGACGGTACTGGAATTGTATTAATCGATGAAATAGACC

TCCATTTACATCCATCATGGCAGCAAAATATTATTCCTCGTCTTGAGAAAACGTTTAAGAATATTCAATTTATAGTCACTCCATTTACATCCATCATGGCAGCAAAATATTATTCCTCGTCTTGAGAAAACGTTTAAGAATATTCAATTTATAGTCAC

GACTCATAGTCCACAAGTTTGTCATACTATTGATAGTCAGAATATATGGTTGTTAAAGAATGGCCAAAAGTTTAAAGCAGACTCATAGTCCACAAGTTTGTCATACTATTGATAGTCAGAATATATGGTTGTTAAAGAATGGCCAAAAGTTTAAAGCA

CCGAAAGGAGTTAGAGGAGCAATATCTTCTTGGGTACTGGAGAACTTGTTCGAAGTTGCTCAAAGGCCGCCAGAGGATACCGAAAGGAGTTAGAGGAGCAATATCTTCTTGGGTACTGGAGAACTTGTTCGAAGTTGCTCAAAGGCCGCCAGAGGATA

AGTACACAAAACTCTTACAGGAATATAAAAATTTAGTATTTTCAGAAAAATATGCTAGTGAAGATGCAAGAAAGCTAGGAGTACACAAAACTCTTACAGGAATATAAAAATTTAGTATTTTCAGAAAAATATGCTAGTGAAGATGCAAGAAAGCTAGG

TGCTACTTTATCCCAACATTTCGGACCGGATGATGAAACCTTAGTTGAGTTAaagctAGAAATTGAAAAAAGAATTTGGTGCTACTTTATCCCAACATTTCGGACCGGATGATGAAACCTTAGTTGAGTTAaagctAGAAATTGAAAAAAGAATTTGG

GAGGATGATTTTGAAAAGGATCAAGATTACAAGGACGACGATGACAAGTAAgaattcaatcaataggagaaatcaatGGGAGGATGATTTTGAAAAGGATCAAGATTACAAGGACGACGATGACAAGTAAgaattcaatcaataggagaaatcaatGG

ATCCATGATTTTGAAAAGGATCAATAAAACTGCTGAAGATCAATTCTTAATTAATTTTAAAGCTCAAAATCCAAATGGGATCCATGATTTTGAAAAGGATCAATAAAACTGCTGAAGATCAATTCTTAATTAATTTTAAAGCTCAAAATCCAAATGGG

ACTTGGGATGAATTTAGGAATCATGAACAAGGTATTTTATATAAGAGGTTAAAGCAACATATTTGCAATGATCAAATGTACTTGGGATGAATTTAGGAATCATGAACAAGGTATTTTATATAAGAGGTTAAAGCAACATATTTGCAATGATCAAATGT

ACCTTTGTGCGTATTGTGAGATAGATTTAGATCGAGAAAATGAACATGAAATAAAAGTAGAGCATTTCAAATCTAAATCACCTTTGTGCGTATTGTGAGATAGATTTAGATCGAGAAAATGAACATGAAATAAAAGTAGAGCATTTCAAATCTAAATC

TGGTTCGCTCCCTGGTGGAAGTAACTGGCATTTAGAGTGGTCTAATCTCTTAGCTGTATGCCTAGGAGGTACAAATACATGGTTCGCTCCCTGGTGGAAGTAACTGGCATTTAGAGTGGTCTAATCTCTTAGCTGTATGCCTAGGAGGTACAAATACA

GGTGATGATTTCGAATTACCAGCTAATCTAAGTTGTGATTCATATAAGTCACATTATGAAGACAAAAATAAAATCAATGGGTGATGATTTCGAATTACCAGCTAATCTAAGTTGTGATTCATATAAGTCACATTATGAAGACAAAAATAAAATCAATG

ATAAAGACTGGACAGGCAAAATCCTGTTACCTTTAACGCTTCCGGATGCACACAATTTTTTTACTTTCGAGAAAGTTACATAAAGACTGGACAGGCAAAATCCTGTTACCTTTAACGCTTCCGGATGCACACAATTTTTTTACTTTCGAGAAAGTTAC

AGGTAAGTTGCTACCTAATGAATCATACTGTAATACTATTAGCATAGATGGTAAACCTGCTGCAGAAACACTAAGTATTAGGTAAGTTGCTACCTAATGAATCATACTGTAATACTATTAGCATAGATGGTAAACCTGCTGCAGAAACACTAAGTATT

GTAACTAAAACAATAGAAGTTCTAAATTTAAACTGCAGCAGGCTAAATAATGCCAGAAGAAAACTGCTGTTTCACTTTAGTAACTAAAACAATAGAAGTTCTAAATTTAAACTGCAGCAGGCTAAATAATGCCAGAAGAAAACTGCTGTTTCACTTTA

ATAATTGCGCACGTGAAAGAAACTTGAGAAAGCTCCATAATCTATTATTACAATGGAATCAAGGTGAGCCTAAATTTTTATAATTGCGCACGTGAAAGAAACTTGAGAAAGCTCCATAATCTATTATTACAATGGAATCAAGGTGAGCCTAAATTTTT

CCAAACGACACGAGATATAATAATTCGTGATGATAGAATCTGCCAAGGGTTACTGAACGGAACGATAAGATATTACCCACCAAACGACACGAGATATAATAATTCGTGATGATAGAATCTGCCAAGGGTTACTGAACGGAACGATAAGATATTACCCA

TACGATGTTCCAGATTACGCTTAATACGATGTTCCAGATTACGCTTAA

SEQ ID NO.4(ATPase-HNH-6×His):SEQ ID NO.4 (ATPase-HNH-6×His):

ATGGAACAGAACTTACCGAGTAGAATAACTAAATTAATTAAAAAATCGGAAAGCGGCGATTTTGCTTCTTCGTATCAGCATGGAACAGAACTTACCGAGTAGAATAACTAAATTAATTAAAAAATCGGAAAGCGGCGATTTTGCTTCTTCGTATCAGC

TTTATAAAGTATTTGGCTCGAAAGAGTACGGAGTTGAGCCAGATGAAAAAATGTCTGATTACTTCAAAGAATTATCAGCTTTATAAAGTATTTGGCTCGAAAGAGTACGGAGTTGAGCCAGATGAAAAAATGTCTGATTACTTCAAAGAATTATCAGC

TAAACAGTTAGAAGGTGGTCAACTGAGAGTTGCTGATATTCATTTGGAAAACTACAAAGGGTTTGAGTCCCTAATAATGTAAACAGTTAGAAGGTGGTCAACTGAGAGTTGCTGATATTCATTTGGAAAACTACAAAGGGTTTGAGTCCCTAATAATG

GATTTTTCCATGAAAAAAAACTCTACAATTTTAGTAGGAAATAATGGCTGTGGGAAAtcgacGATTCTCGATGCAATCCGATTTTTCCATGAAAAAAAACTCTACAATTTTAGTAGGAAATAATGGCTGTGGGAAAtcgacGATTCTCGATGCAATCC

AGAAGGGGTTAACACATCTATCCTCGAGATTATCTACTCGCTCGCATAATGGCGATGGTATCGAAAAACATGAGTTAAGAGAAGGGGTTAACACATCTATCCTCGAGATTATCTACTCGCTCGCATAATGGCGATGGTATCGAAAAACATGAGTTAAG

AAAAGGACAAAACTATGCATCGATCGCTATAAATTACGACTATATGGGAATACGTTTTCCTATGATCATAGCTACAACTAAAAGGACAAAACTATGCATCGATCGCTATAAATTACGACTATATGGGAATACGTTTTCCTATGATCATAGCTACAACT

GAACCTGGTTATGAGGATAGAGCAAAAAGTAACTATAGCGGTATTAATGAGTTAGGAAGCATTTTCAAAACAGCCCATTGAACCTGGTTATGAGGATAGAGCAAAAAGTAACTATAGCGGTATTAATGAGTTAGGAAGCATTTTCAAAACAGCCCATT

CAATCAATCCAAATGTTTCATTTCCTTTAATTGCAATGTATACAGTTGAAAGGGCTAATGACGTTTCTACTAGAGATATCAATCAATCCAAATGTTTCATTTCCTTTAATTGCAATGTATACAGTTGAAAGGGCTAATGACGTTTCTACTAGAGATAT

TGAAaattcAGAAGAAATTAAAGAAGCTCAAATCTGGGATAAATTCAAAGCATATAATAAGAGCCTGACAGGAAAGGCTTGAAaattcAGAAGAAATTAAAGAAGCTCAAATCTGGGATAAATTCAAAGCATATAATAAGAGCCTGACAGGAAAGGCT

GATTTCAAATTATTCTTCAGATGGTTTAAAGAACTAATAGAAATCGAAAACTCTGATAACGCTGATATAACAGCATTAAGATTTCAAATTATTCTTCAGATGGTTTAAAGAACTAATAGAAATCGAAAACTCTGATAACGCTGATATAACAGCATTAA

GAGCAGAGATTCGTGCTAAAGAAAAAGACTTAGACAATCCATTGCTAAAAGCTCTTCTGGCAGAGAATAAAAATTCTGAGAGCAGAGATTCGTGCTAAAGAAAAAGACTTAGACAATCCATTGCTAAAAGCTCTTCTGGCAGAGAATAAAAATTCTGA

GACTACTAAAAAATTGTTAGAAGATCATCAGAACTCTCTGAAAGTTTTAAAAGAGAAATTAAATAGCTATTATTCAGTCGACTACTAAAAAATTGTTAGAAGATCATCAGAACTCTCTGAAAGTTTTAAAAGAGAAATTAAATAGCTATTATTCAGTC

AATAGTAAAACATTACACACTGTTGAAGATGCAATGTATTCTTTCCTTCCTGGTTTTAGCAACCTTAAACTTCAAAGGGAATAGTAAAACATTACACACTGTTGAAGATGCAATGTATTCTTTCCTTCCTGGTTTTAGCAACCTTAAACTTCAAAGGG

CGCCTCTTGATCTGATAGTGGATAAGAATAATGTTTCCTTAAGTGTTCTGCAATTATCTCAAGGTGAAAAAACCATTTTCGCCTCTTGATCTGATAGTGGATAAGAATAATGTTTCCTTAAGTGTTCTGCAATTATCTCAAGGTGAAAAAACCATTTT

AGCATTAATTGCAGATATTGCTCGTAGATTGACATTGTTAAACCCTAATAGTGTTAACCCTTTGGACGGTACTGGAATTAGCATTAATTGCAGATATTGCTCGTAGATTGACATTGTTAAACCCTAATAGTGTTAACCCTTTGGACGGTACTGGAATT

GTATTAATCGATGAAATAGACCTCCATTTACATCCATCATGGCAGCAAAATATTATTCCTCGTCTTGAGAAAACGTTTAGTATTAATCGATGAAATAGACCTCCATTTACATCCATCATGGCAGCAAAATATTATTCCTCGTCTTGAGAAAACGTTTA

AGAATATTCAATTTATAGTCACGACTCATAGTCCACAAGTTTGTCATACTATTGATAGTCAGAATATATGGTTGTTAAAAGAATATTCAATTTATAGTCACGACTCATAGTCCACAAGTTTGTCATACTATTGATAGTCAGAATATATGGTTGTTAAA

GAATGGCCAAAAGTTTAAAGCACCGAAAGGAGTTAGAGGAGCAATATCTTCTTGGGTACTGGAGAACTTGTTCGAAGTTGAATGGCCAAAAGTTTAAAGCACCGAAAGGAGTTAGAGGAGCAATATCTTCTTGGGTACTGGAGAACTTGTTCGAAGTT

GCTCAAAGGCCGCCAGAGGATAAGTACACAAAACTCTTACAGGAATATAAAAATTTAGTATTTTCAGAAAAATATGCTAGCTCAAAGGCCGCCAGAGGATAAGTACACAAAACTCTTACAGGAATATAAAAATTTAGTATTTTCAGAAAAATATGCTA

GTGAAGATGCAAGAAAGCTAGGTGCTACTTTATCCCAACATTTCGGACCGGATGATGAAACCTTAGTTGAGTTAaagctGTGAAGATGCAAGAAAGCTAGGTGCTACTTTATCCCAACATTTCGGACCGGATGATGAAACCTTAGTTGAGTTAaagct

AGAAATTGAAAAAAGAATTTGGGAGGATGATTTTGAAAAGGATCAAGATTACAAGGACGACGATGACAAGTAAgaattcAGAAATTGAAAAAAGAATTTGGGAGGATGATTTTGAAAAGGATCAAGATTACAAGGACGACGATGACAAGTAAgaattc

aatcaataggagaaatcaatGGATCCATGATTTTGAAAAGGATCAATAAAACTGCTGAAGATCAATTCTTAATTAATTTaatcaataggagaaatcaatGGATCCATGATTTTGAAAAGGATCAATAAAACTGCTGAAGATCAATTCTTAATTAATTT

TAAAGCTCAAAATCCAAATGGGACTTGGGATGAATTTAGGAATCATGAACAAGGTATTTTATATAAGAGGTTAAAGCAATAAAGCTCAAAATCCAAATGGGACTTGGGATGAATTTAGGAATCATGAACAAGGTATTTTATATAAGAGGTTAAAGCAA

CATATTTGCAATGATCAAATGTACCTTTGTGCGTATTGTGAGATAGATTTAGATCGAGAAAATGAACATGAAATAAAAGCATATTTGCAATGATCAAATGTACCTTTGTGCGTATTGTGAGATAGATTTAGATCGAGAAAATGAACATGAAATAAAAG

TAGAGCATTTCAAATCTAAATCTGGTTCGCTCCCTGGTGGAAGTAACTGGCATTTAGAGTGGTCTAATCTCTTAGCTGTTAGAGCATTTCAAATCTAAATCTGGTTCGCTCCCTGGTGGAAGTAACTGGCATTTAGAGTGGTCTAATCTCTTAGCTGT

ATGCCTAGGAGGTACAAATACAGGTGATGATTTCGAATTACCAGCTAATCTAAGTTGTGATTCATATAAGTCACATTATATGCCTAGGAGGTACAAATACAGGTGATGATTTCGAATTACCAGCTAATCTAAGTTGTGATTCATATAAGTCACATTAT

GAAGACAAAAATAAAATCAATGATAAAGACTGGACAGGCAAAATCCTGTTACCTTTAACGCTTCCGGATGCACACAATTGAAGACAAAAATAAAATCAATGATAAAGACTGGACAGGCAAAATCCTGTTACCTTTAACGCTTCCGGATGCACACAATT

TTTTTACTTTCGAGAAAGTTACAGGTAAGTTGCTACCTAATGAATCATACTGTAATACTATTAGCATAGATGGTAAACCTTTTTACTTTCGAGAAAGTTACAGGTAAGTTGCTACCTAATGAATCATACTGTAATACTATTAGCATAGATGGTAAACC

TGCTGCAGAAACACTAAGTATTGTAACTAAAACAATAGAAGTTCTAAATTTAAACTGCAGCAGGCTAAATAATGCCAGATGCTGCAGAAACACTAAGTATTGTAACTAAAACAATAGAAGTTCTAAATTTAAACTGCAGCAGGCTAAATAATGCCAGA

AGAAAACTGCTGTTTCACTTTAATAATTGCGCACGTGAAAGAAACTTGAGAAAGCTCCATAATCTATTATTACAATGGAAGAAAACTGCTGTTTCACTTTAATAATTGCGCACGTGAAAGAAACTTGAGAAAGCTCCATAATCTATTATTACAATGGA

ATCAAGGTGAGCCTAAATTTTTCCAAACGACACGAGATATAATAATTCGTGATGATAGAATCTGCCAAGGGTTACTGAAATCAAGGTGAGCCTAAATTTTTCCAAACGACACGAGATATAATAATTCGTGATGATAGAATCTGCCAAGGGTTACTGAA

CGGAACGATAAGATATCACCACCACCACCACCACTAACGGAACGATAAGATATCACCACCACCACCACCACTAA

SEQ ID NO.5(pCDFDuet vector):SEQ ID NO.5 (pCDFDuet vector):

GGGGAATTGTGAGCGGATAACAATTCCCCTGTAGAAATAATTTTGTTTAACTTTAATAAGGAGATATACCATGGGCAGCGGGGAATTGTGAGCGGATAACAATTCCCCTGTAGAAATAATTTTGTTTAACTTTAATAAGGAGATATACCATGGGCAGC

AGCAGCCAGGATCCGAATTCGAGCTCGGCGCGCCTGCAGGTCGACAAGCTTGCGGCCGCATAATGCTTAAGTCGAACAGAGCAGCCAGGATCCGAATTCGAGCTCGGCGCGCCTGCAGGTCGACAAGCTTGCGGCCGCATAATGCTTAAGTCGAACAG

AAAGTAATCGTATTGTACACGGCCGCATAATCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTAAAGTAATCGTATTGTACACGGCCGCATAATCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATT

CCCCATCTTAGTATATTAGTTAAGTATAAGAAGGAGATATACATATGGCAGATCTCAATTGGATATCGGCCGGCCACGCCCCCATCTTAGTATATTAGTTAAGTATAAGAAGGAGATATACATATGGCAGATCTCAATTGGATATCGGCCGGCCACGC

GATCGCTGACGTCGGTACCCTCGAGTCTGGTTCTACTAGCGCAGCTTAATTAACCTAGGCTGCTGCCACCGCTGAGCAAGATCGCTGACGTCGGTACCCTCGAGTCTGGTTCTACTAGCGCAGCTTAATTAACCTAGGCTGCTGCCACCGCTGAGCAA

TAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAACCTCAGGCATTTGAGAAGCACATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAACCTCAGGCATTTGAGAAGCACA

CGGTCACACTGCTTCCGGTAGTCAATAAACCGGTAAACCAGCAATAGACATAAGCGGCTATTTAACGACCCTGCCCTGACGGTCACACTGCTTCCGGTAGTCAATAAACCGGTAAACCAGCAATAGACATAAGCGGCTATTTAACGACCCTGCCCTGA

ACCGACGACCGGGTCATCGTGGCCGGATCTTGCGGCCCCTCGGCTTGAACGAATTGTTAGACATTATTTGCCGACTACCACCGACGACCGGGTCATCGTGGCCGGATCTTGCGGCCCCTCGGCTTGAACGAATTGTTAGACATTATTTGCCGACTACC

TTGGTGATCTCGCCTTTCACGTAGTGGACAAATTCTTCCAACTGATCTGCGCGCGAGGCCAAGCGATCTTCTTCTTGTCTTGGTGATCTCGCCTTTCACGTAGTGGACAAATTCTTCCAACTGATCTGCGCGCGAGGCCAAGCGATCTTCTTCTTGTC

CAAGATAAGCCTGTCTAGCTTCAAGTATGACGGGCTGATACTGGGCCGGCAGGCGCTCCATTGCCCAGTCGGCAGCGACCAAGATAAGCCTGTCTAGCTTCAAGTATGACGGGCTGATACTGGGCCGGCAGGCGCTCCATTGCCCAGTCGGCAGCGAC

ATCCTTCGGCGCGATTTTGCCGGTTACTGCGCTGTACCAAATGCGGGACAACGTAAGCACTACATTTCGCTCATCGCCAATCCTTCGGCGCGATTTTGCCGGTTACTGCGCTGTACCAAATGCGGGACAACGTAAGCACTACATTTCGCTCATCGCCA

GCCCAGTCGGGCGGCGAGTTCCATAGCGTTAAGGTTTCATTTAGCGCCTCAAATAGATCCTGTTCAGGAACCGGATCAAGCCCAGTCGGGCGGCGAGTTCCATAGCGTTAAGGTTTCATTTAGCGCCTCAAATAGATCCTGTTCAGGAACCGGATCAA

AGAGTTCCTCCGCCGCTGGACCTACCAAGGCAACGCTATGTTCTCTTGCTTTTGTCAGCAAGATAGCCAGATCAATGTCAGAGTTCCTCCGCCGCTGGACCTACCAAGGCAACGCTATGTTCTCTTGCTTTTGTCAGCAAGATAGCCAGATCAATGTC

GATCGTGGCTGGCTCGAAGATACCTGCAAGAATGTCATTGCGCTGCCATTCTCCAAATTGCAGTTCGCGCTTAGCTGGAGATCGTGGCTGGCTCGAAGATACCTGCAAGAATGTCATTGCGCTGCCATTCTCCAAATTGCAGTTCGCGCTTAGCTGGA

TAACGCCACGGAATGATGTCGTCGTGCACAACAATGGTGACTTCTACAGCGCGGAGAATCTCGCTCTCTCCAGGGGAAGTAACGCCACGGAATGATGTCGTCGTGCACAACAATGGTGACTTCTACAGCGCGGAGAATCTCGCTCTCTCCAGGGGAAG

CCGAAGTTTCCAAAAGGTCGTTGATCAAAGCTCGCCGCGTTGTTTCATCAAGCCTTACGGTCACCGTAACCAGCAAATCCCGAAGTTTCCAAAAGGTCGTTGATCAAAGCTCGCCGCGTTGTTTCATCAAGCCTTACGGTCACCGTAACCAGCAAATC

AATATCACTGTGTGGCTTCAGGCCGCCATCCACTGCGGAGCCGTACAAATGTACGGCCAGCAACGTCGGTTCGAGATGGAATATCACTGTGTGGCTTCAGGCCGCCATCCACTGCGGAGCCGTACAAATGTACGGCCAGCAACGTCGGTTCGAGATGG

CGCTCGATGACGCCAACTACCTCTGATAGTTGAGTCGATACTTCGGCGATCACCGCTTCCCTCATACTCTTCCTTTTTCCGCTCGATGACGCCAACTACCTCTGATAGTTGAGTCGATACTTCGGCGATCACCGCTTCCCTCATACTCTTCCTTTTTC

AATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAAT

AGCTAGCTCACTCGGTCGCTACGCTCCGGGCGTGAGACTGCGGCGGGCGCTGCGGACACATACAAAGTTACCCACAGATAGCTAGCTCACTCGGTCGCTACGCTCCGGGCGTGAGACTGCGGCGGGCGCTGCGGACACATACAAAGTTACCCACAGAT

TCCGTGGATAAGCAGGGGACTAACATGTGAGGCAAAACAGCAGGGCCGCGCCGGTGGCGTTTTTCCATAGGCTCCGCCCTCCGTGGATAAGCAGGGGACTAACATGTGAGGCAAAACAGCAGGGCCGCGCCGGTGGCGTTTTTCCATAGGCTCCGCCC

TCCTGCCAGAGTTCACATAAACAGACGCTTTTCCGGTGCATCTGTGGGAGCCGTGAGGCTCAACCATGAATCTGACAGTTCCTGCCAGAGTTCACATAAACAGACGCTTTTCCGGTGCATCTGTGGGAGCCGTGAGGCTCAACCATGAATCTGACAGT

ACGGGCGAAACCCGACAGGACTTAAAGATCCCCACCGTTTCCGGCGGGTCGCTCCCTCTTGCGCTCTCCTGTTCCGACCACGGGCGAAACCCGACAGGACTTAAAGATCCCCACCGTTTCCGGCGGGTCGCTCCCTCTTGCGCTCTCCTGTTCCGACC

CTGCCGTTTACCGGATACCTGTTCCGCCTTTCTCCCTTACGGGAAGTGTGGCGCTTTCTCATAGCTCACACACTGGTATCTGCCGTTTACCGGATACCTGTTCCGCCTTTCTCCCTTACGGGAAGTGTGGCGCTTTCTCATAGCTCACACACTGGTAT

CTCGGCTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTAAGCAAGAACTCCCCGTTCAGCCCGACTGCTGCGCCTTATCTCGGCTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTAAGCAAGAACTCCCCGTTCAGCCCGACTGCTGCGCCTTAT

CCGGTAACTGTTCACTTGAGTCCAACCCGGAAAAGCACGGTAAAACGCCACTGGCAGCAGCCATTGGTAACTGGGAGTTCCGGTAACTGTTCACTTGAGTCCAACCCGGAAAAGCACGGTAAAACGCCACTGGCAGCAGCCATTGGTAACTGGGAGTT

CGCAGAGGATTTGTTTAGCTAAACACGCGGTTGCTCTTGAAGTGTGCGCCAAAGTCCGGCTACACTGGAAGGACAGATTCGCAGAGGATTTGTTTAGCTAAACACGCGGTTGCTCTTGAAGTGTGCGCCAAAGTCCGGCTACACTGGAAGGACAGATT

TGGTTGCTGTGCTCTGCGAAAGCCAGTTACCACGGTTAAGCAGTTCCCCAACTGACTTAACCTTCGATCAAACCACCTCTGGTTGCTGTGCTCTGCGAAAGCCAGTTACCACGGTTAAGCAGTTCCCCAACTGACTTAACCTTCGATCAAACCACCTC

CCCAGGTGGTTTTTTCGTTTACAGGGCAAAAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCCCCAGGTGGTTTTTTCGTTTACAGGGCAAAAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTC

TACTGAACCGCTCTAGATTTCAGTGCAATTTATCTCTTCAAATGTAGCACCTGAAGTCAGCCCCATACGATATAAGTTGTACTGAACCGCTCTAGATTTCAGTGCAATTTATCTCTTCAAATGTAGCACCTGAAGTCAGCCCCATACGATATAAGTTG

TAATTCTCATGTTAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGAGATAATTCTCATGTTAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGAGA

TCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCG

TGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCCAGGGTGGTTTTTCTTTTCTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCCAGGGTGGTTTTTCTTTTC

ACCAGTGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAGAGTTGCAGCAAGCGGTCCACGCTGGTTTACCAGTGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAGAGTTGCAGCAAGCGGTCCACGCTGGTTT

GCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGTTAACGGCGGGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCGCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGTTAACGGCGGGATATAACATGAGCTGTCTTCGGTATCGTCGTATCC

CACTACCGAGATGTCCGCACCAACGCGCAGCCCGGACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGCACTACCGAGATGTCCGCACCAACGCGCAGCCCGGACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTG

GCAACCAGCATCGCAGTGGGAACGATGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTGCAACCAGCATCGCAGTGGGAACGATGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGT

CGCCTTCCCGTTCCGCTATCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGACGCCTTCCCGTTCCGCTATCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGA

GACAGAACTTAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTAGACAGAACTTAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTA

CCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAACATTAGTGCCCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAACATTAGTGC

AGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTGACGCGTTGCGCGAGAAGAGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTGACGCGTTGCGCGAGAAG

ATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACACCACCACGCTGGCACCCAGTTGATCGATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACACCACCACGCTGGCACCCAGTTGATCG

GCGCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGGGCCAGACTGGAGGTGGCAACGCCAATCAGCAACGGCGCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGGGCCAGACTGGAGGTGGCAACGCCAATCAGCAACG

ACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGGGAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGGGAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCG

CGTTTTCGCAGAAACGTGGCTGGCCTGGTTCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACACGTTTTCGCAGAAACGTGGCTGGCCTGGTTCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACA

TCGTATAACGTTACTGGTTTCACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTCGTATAACGTTACTGGTTTCACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGG

TTTTGCGCCATTCGATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAATTAATACGACTCATTTTGCGCCATTCGATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAATTAATACGACTCA

CTATACTATA

SEQ ID NO.6(pET28 vector):SEQ ID NO.6 (pET28 vector):

TGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTTGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTT

GCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTC

TAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGG

TTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTC

TTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCT

ATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGTTTACAATTTCAGGTGGATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGTTTACAATTTCAGGTGG

CACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAATCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAAT

TAATTCTTAGAAAAACTCATCGAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGATAATTCTTAGAAAAACTCATCGAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGA

AAAAGCCGTTTCTGTAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGAAAAAGCCGTTTCTGTAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGA

TTCCGACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCATGTTCCGACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCATG

AGTGACGACTGAATCCGGTGAGAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCAGCCATTACGCAGTGACGACTGAATCCGGTGAGAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCAGCCATTACGC

TCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGAGACGAAATACGCGATCGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGAGACGAAATACGCGATCGC

TGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACACTGCCAGCGCATCAACAATATTTTCACCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACACTGCCAGCGCATCAACAATATTTTCACC

TGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGGGGATCGCAGTGGTGAGTAACCATGCATCATCAGGATGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGGGGATCGCAGTGGTGAGTAACCATGCATCATCAGGA

GTACGGATAAAATGCTTGATGGTCGGAAGAGGCATAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATGTACGGATAAAATGCTTGATGGTCGGAAGAGGCATAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACAT

CATTGGCAACGCTACCTTTGCCATGTTTCAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCCATTGGCAACGCTACCTTTGCCATGTTTCAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGC

ACCTGATTGCCCGACATTATCGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTAACCTGATTGCCCGACATTATCGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTA

GAGCAAGACGTTTCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCGAGCAAGACGTTTCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTC

ATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAG

ATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCA

AGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCG

TAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTG

CCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAAC

GGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAA

AGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGG

AGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTG

ATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCT

TTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCG

CTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCTCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCT

TACGCATCTGTGCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCTACGCATCTGTGCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCC

AGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGAAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGA

CGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCAC

CGTCATCACCGAAACGCGCGAGGCAGCTGCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCTGCCTGCGTCATCACCGAAACGCGCGAGGCAGCTGCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCTGCCTG

TTCATCCGCGTCCAGCTCGTTGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGTTCATCCGCGTCCAGCTCGTTGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCG

GTTTTTTCCTGTTTGGTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGGTTTTTTCCTGTTTGGTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAG

AGAGGATGCTCACGATACGGGTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACTGGCGGTAGAGGATGCTCACGATACGGGTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACTGGCGGT

ATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGATGTAGGTGTTCCACAGATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGATGTAGGTGTTCCACAG

GGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCTGACTTCCGCGTTTCCAGACTTTACGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCTGACTTCCGCGTTTCCAGACTTTACG

AAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGACGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCAAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGACGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTC

GCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAACCCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAACCCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATC

ATGCGCACCCGTGGGGCCGCCATGCCGGCGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGAATGCGCACCCGTGGGGCCGCCATGCCGGCGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGA

AGGCTTGAGCGAGGGCGTGCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTCAGGCTTGAGCGAGGGCGTGCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTC

CTCGCCGAAAATGACCCAGAGCGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCGCTCGCCGAAAATGACCCAGAGCGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCG

ACGATAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGAGATCCCGGTGACGATAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGAGATCCCGGTG

CCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCT

GCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCCAGGGTGGTTTTTCTTTTCACCAGTGAGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCCAGGGTGGTTTTTCTTTTCACCAGTGA

GACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAGAGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAGAGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGC

AGGCGAAAATCCTGTTTGATGGTGGTTAACGGCGGGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGGCGAAAATCCTGTTTGATGGTGGTTAACGGCGGGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCG

AGATATCCGCACCAACGCGCAGCCCGGACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAGAGATATCCGCACCAACGCGCAGCCCGGACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAG

CATCGCAGTGGGAACGATGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCCCATCGCAGTGGGAACGATGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCC

CGTTCCGCTATCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAACCGTTCCGCTATCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAAC

TTAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTACCGTCTTCTTAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTACCGTCTTC

ATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAACATTAGTGCAGGCAGCTATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAACATTAGTGCAGGCAGCT

TCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTGACGCGTTGCGCGAGAAGATTGTGCATCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTGACGCGTTGCGCGAGAAGATTGTGCA

CCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACACCACCACGCTGGCACCCAGTTGATCGGCGCGAGACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACACCACCACGCTGGCACCCAGTTGATCGGCGCGAGA

TTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGGGCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGTTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGGGCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTG

CCCGCCAGTTGTTGTGCCACGCGGTTGGGAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCCCGCCAGTTGTTGTGCCACGCGGTTGGGAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCG

CAGAAACGTGGCTGGCCTGGTTCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAACAGAAACGTGGCTGGCCTGGTTCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAA

CGTTACTGGTTTCACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTTTTGCGCCGTTACTGGTTTCACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTTTTGCGC

CATTCGATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGAGGCATTCGATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGAGG

CCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCACGGGGCCTGCCACCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCACGGGGCCTGCCA

CCATACCCACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCCATCGGTGATGTCGGCGATATACCATACCCACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCCATCGGTGATGTCGGCGATATA

GGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCGTCCGGCGTAGAGGATCGAGATCTCGATCCCGGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCGTCCGGCGTAGAGGATCGAGATCTCGATCCCG

CGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAACGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAA

GAAGGAGATATACCATGGgccatcatcatcatcatcacagcggcgaaaacctgtattttcagggcgctagcGGATCCGGGAAGGAGATATACCATGGgccatcatcatcatcatcacagcggcgaaaacctgtattttcagggcgctagcGGATCCGG

CTTACTAAAAGCCAGATAACAGTATGCGTATTTGCGCGCTGATTTTTGCGGTATAAGAATATATACTGATATGTATACCCTTACTAAAAGCCAGATAACAGTATGCGTATTTGCGCGCTGATTTTTGCGGTATAAGAATATATACTGATATGTATACC

CGAAGTATGTCAAAAAGAGGTATGCTatgaagcagcgtattacagtgacaGTTGACAGCGACAGCTATCAGTTGCTCAACGAAGTATGTCAAAAAGAGGTATGCTatgaagcagcgtattacagtgacaGTTGACAGCGACAGCTATCAGTTGCTCAA

GGCATATATGATGTCAATATCTCCGGTCTGGTAAGCACAACCATGCAGAATGAAGCCCGTCGTCTGCGTGCCGAACGCTGGCATATATGATGTCAATATCTCCGGTCTGGTAAGCACAACCATGCAGAATGAAGCCCGTCGTCTGCGTGCCGAACGCT

GGAAAGCGGAAAATCAGGAAGGGATGGCTGAGGTCGCCCGGTTTATTGAAATGAACGGctcttttgctgacgagaacagGGAAAGCGGAAAATCAGGAAGGGATGGCTGAGGTCGCCCGGTTTATTGAAATGAACGGctcttttgctgacgagaacag

ggGCTGGTGAAatgcagtttaaggtttacacctataaaagagagagccgttatcgtctgtttgtggatgtacagagtgaggGCTGGTGAAatgcagtttaaggtttacacctataaaagagagagccgttatcgtctgtttgtggatgtacagagtga

tattattgacacgcccgggcgacggatggtgatccccctggccagtgcacgtctgctgtcagataaagtctcccgtgaatattattgacacgcccgggcgacggatggtgatccccctggccagtgcacgtctgctgtcagataaagtctcccgtgaa

ctttacccggtggtgcatatcggggatgaaagctggcgcatgatgaccaccgatatggccagtgtgccggtctccgttactttacccggtggtgcatatcggggatgaaagctggcgcatgatgaccaccgatatggccagtgtgccggtctccgtta

tcggggaagaagtggctgatctcagccaccgcgaaaatgacatcaaaaacgccattaacctgatgttctggggaatatatcggggaagaagtggctgatctcagccaccgcgaaaatgacatcaaaaacgccattaacctgatgttctggggaatata

aATGTCAGGCTCCCTTATACACAGCCAGTCTGCAGGAATTCCCGACCCATCATCAACGGCGAGGAGGGAATTACCATACaATGTCAGGCTCCCTTATACACAGCCAGTCTGCAGGAATTCCCGACCCATCATCAACGGCGAGGAGGGAATTACCATAC

TGAAACTGTCTCCCAAGACAAGTGTTTTGAACATAGCCGCCGTGGAACAGGATCATCGTGGGGTCTTCAAGTGCATAGCTGAAACTGTCTCCCAAGACAAGTGTTTTGAACATAGCCGCCGTGGAACAGGATCATCGTGGGGTCTTCAAGTGCATAGC

CGAAAATAAGGCAGGGTCAAGTTTCACAACATCGGAGCTGAAAGTCAACTGAAAGCTTGCGGCCGCACTCGAGCACCACCGAAAATAAGGCAGGGTCAAGTTTCACAACATCGGAGCTGAAAGTCAACTGAAAGCTTGCGGCCGCACTCGAGCACCAC

CACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAAC

TAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGAT

实施例1HNH细胞毒性实验及其毒性抑制机制Example 1 HNH cytotoxicity experiment and its cytotoxicity inhibition mechanism

在蛋白表达过程中,我们将HNH蛋白(SEQ ID NO.1)的目的基因插入pET28载体(SEQ ID NO.6)BamHI/HindIII酶切位点之间构建表达HNH蛋白的质粒,将质粒转入大肠杆菌BL21(DE3)细菌进行表达,发现平板上可以长出正常的菌斑,挑单克隆培养时细菌的OD600值可正常培养至0.6-0.8。然而,一旦加入IPTG诱导表达,菌液会由浑浊逐渐变清亮。如图所示:左侧离心管中加入0.2mM IPTG诱导1h后的细菌变得澄清,右侧未诱导菌1h后仍然浑浊(见图7)。During the protein expression process, we inserted the target gene of HNH protein (SEQ ID NO.1) into the BamHI/HindIII restriction sites of pET28 vector (SEQ ID NO.6) to construct a plasmid expressing HNH protein, and transferred the plasmid into Escherichia coli BL21 (DE3) bacteria for expression. It was found that normal plaques could grow on the plate, and the OD 600 value of the bacteria could be normally cultured to 0.6-0.8 when a single clone was selected for culture. However, once IPTG was added to induce expression, the bacterial solution would gradually change from turbid to clear. As shown in the figure: the bacteria in the left centrifuge tube became clear after 1 hour of induction with 0.2mM IPTG, while the uninduced bacteria on the right were still turbid after 1 hour (see Figure 7).

Retron系统在大肠杆菌中作为一个整体发挥作用,HNH蛋白可能存在细胞毒性,因此我们推测在正常生理条件下,Retron-Eco4完整系统若不存在毒性,则系统中是否存在某一组分抑制了HNH的毒性。为了验证这一推测,我们进行了单组分缺失突变和细菌毒性实验。The Retron system functions as a whole in E. coli, and the HNH protein may be cytotoxic, so we speculated that under normal physiological conditions, if the Retron-Eco4 complete system is not toxic, then there is a component in the system that inhibits the toxicity of HNH. To verify this speculation, we performed single-component deletion mutation and bacterial toxicity experiments.

为了鉴定Retron-Eco4系统中抑制HNH的毒性的组分,设计了不同的引物(如表1),构建了Retron-Eco4完整组分质粒与单组分缺失质粒(ΔRT,ΔATPase,ΔHNH),如图1示,将所有基因克隆至pCDFDuet载体上,再统一转化至BL21(DE3)细菌中,进行细胞毒性的测试。In order to identify the components that inhibit the toxicity of HNH in the Retron-Eco4 system, different primers were designed (as shown in Table 1), and the Retron-Eco4 complete component plasmid and single-component deletion plasmid (ΔRT, ΔATPase, ΔHNH) were constructed. As shown in Figure 1, all genes were cloned into the pCDFDuet vector and then uniformly transformed into BL21 (DE3) bacteria for cytotoxicity testing.

鉴于Retron-Sen2系统中的效应蛋白ADP-核糖基转移酶是低温毒性的毒素蛋白,Retron-Eco9的效应蛋白ADP-核糖基转移酶在37℃条件和低温条件(低于25℃)下均存在细胞毒性。于是,本研究中探究了HNH在37℃与18℃不同温度下是否存在毒性。不仅如此,因为实验中的诱导剂是IPTG,IPTG对细菌的生长本身就存在一定的毒性,为了排除这一影响,本实验参考了2022年Nature杂志(Jacob Bobonis et al,Bacterial retrons encodephage-defending tripartite toxin–antitoxin systems,2022,Nature)有关Retron-Sen2系统的实验方法,设置了未诱导组(no IPTG)、低浓度IPTG组(0.1mM)、高浓度IPTG组(1mM)。每个实验条件设置三组平行重复。Given that the effector protein ADP-ribosyltransferase in the Retron-Sen2 system is a toxin protein with low temperature toxicity, the effector protein ADP-ribosyltransferase of Retron-Eco9 is cytotoxic under both 37°C and low temperature conditions (below 25°C). Therefore, this study explored whether HNH is toxic at different temperatures of 37°C and 18°C. In addition, because the inducer in the experiment is IPTG, IPTG itself has a certain toxicity to the growth of bacteria. In order to exclude this effect, this experiment referred to the experimental method of the Retron-Sen2 system in Nature magazine in 2022 (Jacob Bobonis et al, Bacterial retrons encodephage-defending tripartite toxin–antitoxin systems, 2022, Nature), and set up an uninduced group (no IPTG), a low concentration IPTG group (0.1mM), and a high concentration IPTG group (1mM). Three groups of parallel replicates were set for each experimental condition.

表1:系统单组分缺失突变引物Table 1: Systematic single-component deletion mutation primers

实验结果图2-A显示:(1)含HNH质粒的大肠杆菌,低浓度IPTG组与高浓度IPTG组的菌斑较于未诱导组的菌斑数量明显减少,形态也不均一;(2)含Retron-Eco4完整系统质粒的细菌,在未诱导组和低浓度IPTG组生长良好,在高IPTG组中因为IPTG的毒性影响生长不好;(3)但仍然可以观察到HNH的高IPTG组细菌较Retron-Eco4的高IPTG组的细菌斑数少,这里可以排除高IPTG浓度对细菌的毒性作用。于是实验结果表明HNH在不同温度条件下均存在细胞毒性,而完整的Retron-Eco4系统在不同温度条件下均无细胞毒性。The experimental results in Figure 2-A show that: (1) the number of plaques of E. coli containing HNH plasmid in the low-concentration IPTG group and the high-concentration IPTG group was significantly reduced compared with the uninduced group, and the morphology was also uneven; (2) bacteria containing the Retron-Eco4 complete system plasmid grew well in the uninduced group and the low-concentration IPTG group, but did not grow well in the high-IPTG group due to the toxicity of IPTG; (3) However, it can still be observed that the number of bacterial plaques in the high-IPTG group of HNH was less than that in the high-IPTG group of Retron-Eco4, which can rule out the toxic effect of high IPTG concentration on bacteria. Therefore, the experimental results show that HNH is cytotoxic under different temperature conditions, while the complete Retron-Eco4 system is not cytotoxic under different temperature conditions.

图2-B中包含ΔRT与ΔHNH质粒的细菌在低IPTG诱导(IPTG low)后,不同温度条件下的菌斑数与图2-A中完整Retron-Eco4系统(IPTG low)的菌斑相比没有明显的细胞毒性,比图2-A中单独HNH的菌斑数量多(IPTG low),高IPTG组情况一致;但包含ΔATPase质粒的菌在不同温度条件下呈现菌斑大小不一的现象,高IPTG诱导与低IPTG诱导后后的菌斑相比于完整Retron-Eco4系统明显减少。于是得出结论,在完整的系统中,当ATPase缺失以后,HNH的毒素作用被释放,可以理解为ATPase抑制HNH的毒性。In Figure 2-B, after low IPTG induction (IPTG low), the number of plaques of bacteria containing ΔRT and ΔHNH plasmids under different temperature conditions showed no obvious cytotoxicity compared with the plaques of the complete Retron-Eco4 system (IPTG low) in Figure 2-A, and was greater than the number of plaques of HNH alone in Figure 2-A (IPTG low), which was consistent with the high IPTG group; however, bacteria containing ΔATPase plasmids showed different plaque sizes under different temperature conditions, and the plaques after high IPTG induction and low IPTG induction were significantly reduced compared with the complete Retron-Eco4 system. Therefore, it was concluded that in the complete system, when ATPase was missing, the toxic effect of HNH was released, which can be understood as ATPase inhibiting the toxicity of HNH.

综上所述,细胞毒性实验研究结果表明,完整的Retron-Eco4系统不存在毒性,单独表达HNH在不同温度下均存在细胞毒性,ATPase在不同温度下均表现出HNH毒性抑制作用,提示ATPase与HNH可能在生理条件下具有相互作用,进一步提示ATPase与HNH共表达是获得可溶性HNH蛋白的重要途径。In summary, the results of the cytotoxicity experiment showed that the complete Retron-Eco4 system was not toxic, HNH expressed alone was cytotoxic at different temperatures, and ATPase showed HNH toxicity inhibition at different temperatures, indicating that ATPase and HNH may interact under physiological conditions, and further suggesting that co-expression of ATPase and HNH is an important way to obtain soluble HNH protein.

实施例2HNH与ATPase存在相互作用Example 2 HNH interacts with ATPase

本项目首先构建了pCDFDuet-ATPase-FLAG-HNH-HA表达质粒,如图3-A所示,在ATPase的C端带上FLAG标签,在HA蛋白的C端带上HA标签。随后将构建好的质粒转化至大肠杆菌BL21(DE3)表达感受态细胞中,0.2mM IPTG诱导表达40-50mL菌液,收集菌体后冰上超声破碎菌体再低温离心获得包含可溶性ATPase-FLAG与HNH-HA蛋白的上清。随后,利用FLAG标签免疫磁珠吸附ATPase-FLAG蛋白,再鉴定ATPase-FLAG蛋白是否可以将HNH-HA蛋白结合并拉下,以此判断ATPase与HNH蛋白在生理条件下的相互作用。This project first constructed the pCDFDuet-ATPase-FLAG-HNH-HA expression plasmid, as shown in Figure 3-A, with a FLAG tag at the C-terminus of ATPase and an HA tag at the C-terminus of HA protein. The constructed plasmid was then transformed into E. coli BL21 (DE3) expression competent cells, 0.2mM IPTG induced expression of 40-50mL bacterial solution, and the cells were collected and ultrasonically disrupted on ice and then centrifuged at low temperature to obtain the supernatant containing soluble ATPase-FLAG and HNH-HA proteins. Subsequently, the ATPase-FLAG protein was adsorbed using FLAG-tagged immunomagnetic beads, and then it was determined whether the ATPase-FLAG protein could bind to and pull down the HNH-HA protein, so as to determine the interaction between ATPase and HNH protein under physiological conditions.

图3-A的SDS-PAGE检测结果显示:在FLAG免疫磁珠的洗脱样品中包含ATPase-FLAG与HNH-HA的理论大小的蛋白条带,结合图3-B中在裂解上清和Elution样品中均能沉淀出FLAG标签蛋白,表示ATPase-FLAG蛋白在样品中客观存在并且可以进行有效沉淀。将同一张膜上的HNH-HA蛋白理论位置进行切割进行后续的HA沉淀,结果显示FLAG免疫磁珠洗脱样品中既包含ATPase也包含HNH-HA,这代表ATPase和HNH具有生理性相互作用。但是在原本的裂解液中没有曝出HNH-HA的条带,猜测是原本的HNH含量少,ATPase的亲和类似一个富集的过程。总的来说,此实验与前述细菌毒性实验、共表达实验结果一致,证明ATPase与HNH有结合能力为进一步优化HNH蛋白的表达纯化方法提供了基础。The SDS-PAGE test results in Figure 3-A show that the eluted sample of FLAG immunomagnetic beads contains protein bands of theoretical sizes of ATPase-FLAG and HNH-HA. Combined with the precipitated FLAG-tagged protein in both the lysate supernatant and the elution sample in Figure 3-B, it indicates that the ATPase-FLAG protein objectively exists in the sample and can be effectively precipitated. The theoretical position of the HNH-HA protein on the same membrane was cut for subsequent HA precipitation. The results showed that the eluted sample of FLAG immunomagnetic beads contained both ATPase and HNH-HA, which means that ATPase and HNH have physiological interactions. However, no HNH-HA band was exposed in the original lysate. It is speculated that the original HNH content is low, and the affinity of ATPase is similar to an enrichment process. In general, this experiment is consistent with the results of the aforementioned bacterial toxicity experiment and co-expression experiment, proving that ATPase and HNH have the ability to bind, which provides a basis for further optimization of the expression and purification method of HNH protein.

实施例3HNH蛋白的表达纯化方式的优化Example 3 Optimization of the expression and purification method of HNH protein

先构建pCDFDuet-6×His-ATPase-HNH与pCDFDuet-ATPase-HNH-6×His两个共表达质粒,此步是将亲和标签分别带在ATPase蛋白和HNH蛋白上,双重验证彼此的相互作用。蛋白表达的具体步骤如下:First, construct two co-expression plasmids, pCDFDuet-6×His-ATPase-HNH and pCDFDuet-ATPase-HNH-6×His. This step is to carry affinity tags on the ATPase protein and HNH protein respectively to double verify the interaction between them. The specific steps of protein expression are as follows:

1)质粒构建。先构建pCDFDuet-6×His-ATPase-HNH与pCDFDuet-ATPase-HNH-6×His两个共表达质粒,6×His-ATPase-HNH和ATPase-HNH-6×His具体序列分别见SEQ IDNO.3和SEQ ID NO.4。目的序列插入在pCDFDuet载体第一个T7启动子后的BamHI/HindIII酶切位点之间。1) Plasmid construction. First, construct two co-expression plasmids, pCDFDuet-6×His-ATPase-HNH and pCDFDuet-ATPase-HNH-6×His. The specific sequences of 6×His-ATPase-HNH and ATPase-HNH-6×His are shown in SEQ ID NO.3 and SEQ ID NO.4, respectively. The target sequence is inserted between the BamHI/HindIII restriction sites after the first T7 promoter of the pCDFDuet vector.

2)质粒转化。实验将约100ng质粒转进大肠杆菌BL21(DE3)表达感受态细胞内,迅速将细胞置于冰上,冰浴30min后42℃热激60-90s,冰上放置2-3min,随后往细胞内加入400μL无抗LB,混匀后置于摇床中,37℃、200rpm复苏培养1h。培养物3000rpm离心5min,弃350μLLB后利用剩余培养基混匀细胞沉淀,并均匀涂抹至对应质粒抗性(链霉素50μg/mL)的琼脂平板上,平板倒置并于37℃孵箱过夜培养。2) Plasmid transformation. In the experiment, about 100 ng of plasmid was transferred into the expression competent cells of E. coli BL21 (DE3), and the cells were quickly placed on ice. After ice bathing for 30 minutes, they were heat-shocked at 42°C for 60-90 seconds and placed on ice for 2-3 minutes. Then 400 μL of LB without antibiotics was added to the cells, mixed and placed in a shaker, and revived and cultured at 37°C and 200 rpm for 1 hour. The culture was centrifuged at 3000 rpm for 5 minutes, and 350 μL of LB was discarded. The cell pellet was mixed with the remaining culture medium and evenly spread on the agar plate corresponding to the plasmid resistance (streptomycin 50 μg/mL). The plate was inverted and cultured in an incubator at 37°C overnight.

3)小量培养。本项目挑单克隆于相应抗性(链霉素50μg/mL)的LB中,在摇床中37℃、220rpm培养至大肠杆菌OD600值达到0.6-0.8之间,再加入终浓度0.2mM的IPTG、18℃诱导表达12-16h。3) Small-scale culture. In this project, a single clone was selected in LB with corresponding resistance (streptomycin 50 μg/mL), and cultured in a shaker at 37°C and 220 rpm until the OD 600 value of E. coli reached between 0.6 and 0.8, and then IPTG was added at a final concentration of 0.2 mM and induced for expression at 18°C for 12-16 hours.

如图4所示,其区别在于将亲和标签分别带在ATPase与HNH蛋白上,用以交叉验证两者的相互作用,并比较富集效果。将构建好的两种质粒转化至表达感受态细胞BL21(DE3)中,再进行大肠杆菌的培养和蛋白的表达。对表达蛋白进行镍亲和层析SDS-PAGE电泳检测。As shown in Figure 4, the difference is that the affinity tags are respectively carried on the ATPase and HNH proteins to cross-validate the interaction between the two and compare the enrichment effect. The two constructed plasmids were transformed into expression competent cells BL21 (DE3), and then Escherichia coli was cultured and the protein was expressed. The expressed protein was detected by nickel affinity chromatography SDS-PAGE electrophoresis.

实验结果如图5-A所示,当His6标签带在HNH蛋白的C端时,少量表达的HNH蛋白结合了对应少量的ATPase蛋白。当His6标签带在ATPase蛋白的N端上时,大量表达的ATPase蛋白可以带出少量表达的HNH蛋白(图5-B)。两种表达质粒蛋白表达结果表明,标签带在ATPase蛋白上拉下来的HNH蛋白较多(6L His6-ATPase菌可以获得约2-3mg HNH,6L His6-HNH菌可以获得约1-2mg HNH),于是后续选取了pCDFDuet-His6-ATPase-HNH质粒进行HNH蛋白的表达。The experimental results are shown in Figure 5-A. When the His 6 tag is at the C-terminus of the HNH protein, a small amount of HNH protein expressed binds to a corresponding small amount of ATPase protein. When the His 6 tag is at the N-terminus of the ATPase protein, a large amount of ATPase protein expressed can bring out a small amount of HNH protein expressed (Figure 5-B). The protein expression results of the two expression plasmids showed that the tag pulled down more HNH protein on the ATPase protein (6L His 6 -ATPase bacteria can obtain about 2-3mg HNH, 6L His 6 -HNH bacteria can obtain about 1-2mg HNH), so the pCDFDuet-His 6 -ATPase-HNH plasmid was selected for the expression of HNH protein.

随后,我们将Ni-NTA初纯产物利用SuperdexTM 200凝胶过滤层析进行了进一步纯化。按照预期,初纯产物通过凝胶过滤层析可以获得ATPase与HNH均一的稳定复合物,ATPase蛋白的分子量约为62.8kDa,HNH蛋白的分子量约为30.2kDa,理论出峰位置在11-12mL之间。结果如图5-C所示,“Peak 1”出峰位置在11-12mL之间,此处出峰蛋白的理论分子量约为400kDa,结合SDS-PAGE结果证实“Peak 1”有且仅有ATPase蛋白,因此推测“Peak1”为六聚或七聚的ATPase。“Peak 2”为最主要、最对称的蛋白,出峰位置在13-14mL,此处出峰蛋白的理论分子量约为158kDa,SDS-PAGE结果表明“Peak 2”有且仅有ATPase蛋白,因此“peak2”是二聚状态ATPase。“Peak 3”出峰位置在16-17mL之间,此处出峰蛋白的理论分子量约为29kDa,SDS-PAGE结果表明“Peak 3”主要是单体HNH蛋白。Subsequently, we further purified the Ni-NTA primary pure product using Superdex TM 200 gel filtration chromatography. As expected, the primary pure product can obtain a uniform and stable complex of ATPase and HNH through gel filtration chromatography. The molecular weight of ATPase protein is about 62.8kDa, and the molecular weight of HNH protein is about 30.2kDa. The theoretical peak position is between 11-12mL. The results are shown in Figure 5-C. The peak position of "Peak 1" is between 11-12mL. The theoretical molecular weight of the peak protein here is about 400kDa. Combined with the SDS-PAGE results, it is confirmed that "Peak 1" has and only has ATPase protein, so it is speculated that "Peak 1" is a hexameric or heptameric ATPase. "Peak 2" is the most important and symmetrical protein, with a peak position of 13-14mL. The theoretical molecular weight of the peak protein here is about 158kDa. The SDS-PAGE results show that "Peak 2" has and only has ATPase protein, so "peak2" is a dimeric ATPase. The peak position of "Peak 3" is between 16-17mL. The theoretical molecular weight of the peak protein here is about 29kDa. The SDS-PAGE results show that "Peak 3" is mainly monomeric HNH protein.

共表达实验结果表明,ATPase与HNH存在直接结合,但其结合不稳定或者结合力不强,因此在分子筛层析过程中会分离开来。推测是由于ATP性质不稳定,在蛋白纯化过程中ATP会不断被消耗,ATPase受ATP水解的影响构型发生变化,从而与HNH分离开,最终得以获得单独的HNH蛋白。通过这种表达纯化方法,我们成功获得单一的HNH蛋白,为后续HNH酶活性研究奠定了基础。The results of the co-expression experiment showed that ATPase and HNH bind directly, but the binding is unstable or weak, so they are separated during the molecular sieve chromatography process. It is speculated that due to the unstable nature of ATP, ATP is continuously consumed during the protein purification process, and the conformation of ATPase changes due to ATP hydrolysis, thereby separating from HNH and finally obtaining a single HNH protein. Through this expression and purification method, we successfully obtained a single HNH protein, laying the foundation for subsequent HNH enzyme activity research.

实施例4纯化HNH的酶活检测Example 4 Enzyme Activity Detection of Purified HNH

细菌宿主的基因组和噬菌体基因组是超螺旋结构,因此我们以处于超螺旋结构pUC19质粒作为切割底物,检测HNH(纯化的蛋白)是否具有内切酶活性以及切割单链还是双链DNA。实验设置三个组:超螺旋质粒(提取的pUC19)、线性质粒(用50U商业化EcoRI高保真酶处理后的pUC19质粒,Linear状态)、Nicked质粒(用50U商业化BspQI酶处理后的pUC19,切成单链缺口的Nicked状态),分别对应HNH无内切酶活性、HNH切割双链DNA、HNH切割单链DNA三种情况。Nicked最终释放成开口螺旋状态(Open circular)。The genome of the bacterial host and the phage genome are supercoiled structures, so we used the supercoiled pUC19 plasmid as a cutting substrate to detect whether HNH (purified protein) has endonuclease activity and whether it cuts single-stranded or double-stranded DNA. The experiment set up three groups: supercoiled plasmid (extracted pUC19), linear plasmid (pUC19 plasmid treated with 50U commercial EcoRI high-fidelity enzyme, Linear state), Nicked plasmid (pUC19 treated with 50U commercial BspQI enzyme, Nicked state with single-stranded gaps), corresponding to three situations: HNH has no endonuclease activity, HNH cuts double-stranded DNA, and HNH cuts single-stranded DNA. Nicked is finally released into an open spiral state (Open circular).

实验结果如图6-A所示,在琼脂糖凝胶电泳中,超螺旋状态的pUC19由于结构紧密,所以电泳速率最快,线性化的pUC19条带位置处在中间,结构松散的开口状态pUC19电泳速率最慢,条带处在最上方。HNH在蛋白浓度为100nM条件下可将200ng超螺旋pUC19切成Nicked状态,并且浓度达到1μM时可将200ng pUC19基本切割完全,有Linear状态的切割产物,但主要是Nicked状态的切割产物,表明HNH具备切割单链DNA的切口酶活性(nickaseactivity)。The experimental results are shown in Figure 6-A. In agarose gel electrophoresis, the supercoiled pUC19 has the fastest electrophoresis rate due to its compact structure. The linearized pUC19 band is in the middle. The loosely structured open pUC19 has the slowest electrophoresis rate, with the band at the top. HNH can cut 200ng of supercoiled pUC19 into a Nicked state at a protein concentration of 100nM, and can basically cut 200ng of pUC19 completely when the concentration reaches 1μM. There are cleavage products in the Linear state, but mainly in the Nicked state, indicating that HNH has nickase activity for cutting single-stranded DNA.

已知HNH内切酶的活性具备二价金属离子Mg2+依赖的特点,于是接下来测试了一些常见二价金属离子对HNH的切口酶活的影响,对照组为未经处理的pUC19和加入金属离子螯合剂EDTA的反应体系,实验组中包含1mM金属离子,结果如图6-B所示,除去Zn2+外,Mg2+、Mn2 +、Ca2+、Ni2+均可促进HNH的切割活性。It is known that the activity of HNH endonuclease is dependent on the divalent metal ion Mg2+ , so the effects of some common divalent metal ions on the incision activity of HNH were tested next. The control group was untreated pUC19 and the reaction system with the addition of metal ion chelator EDTA. The experimental group contained 1 mM metal ions. The results are shown in Figure 6-B. Except for Zn2 + , Mg2+ , Mn2 + , Ca2 + , and Ni2 + can all promote the cutting activity of HNH.

对所公开的实施例的上述说明,使本领域专业技术人员能够实现或使用本发明。对上述实施例的多种修改对本领域的专业技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例,而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to the above embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.

Claims (10)

1.一种HNH毒性蛋白表达载体,所述载体包含ATPase编码框和HNH核酸酶编码框,且ATPase编码框和HNH核酸酶编码框可同时独立表达。1. An HNH toxic protein expression vector, the vector comprising an ATPase coding frame and an HNH nuclease coding frame, and the ATPase coding frame and the HNH nuclease coding frame can be expressed independently at the same time. 2.根据权利要求1所述的载体,其特征在于,所述ATPase编码框和HNH编码框核酸酶均为来自大肠杆菌Retron-Eco4系统的ATPase编码框和HNH核酸酶编码框。2. The vector according to claim 1, characterized in that the ATPase coding frame and the HNH coding frame nuclease are both ATPase coding frame and HNH nuclease coding frame from the Escherichia coli Retron-Eco4 system. 3.根据权利要求1所述的载体,其特征在于,ATPase编码框连接一个标签蛋白编码框,所述标签蛋白编码框与ATPase编码框一起表达出含有标签蛋白和ATPase的融合蛋白。3. The vector according to claim 1 is characterized in that the ATPase coding frame is connected to a tag protein coding frame, and the tag protein coding frame and the ATPase coding frame together express a fusion protein containing the tag protein and ATPase. 4.根据权利要求1所述的载体,其特征在于,HNH编码框核酸酶位于ATPase编码框的下游,二者之间含有间隔序列,所述间隔序列可使HNH核酸酶编码框和ATPase编码框独立表达。4. The vector according to claim 1 is characterized in that the HNH nuclease coding frame is located downstream of the ATPase coding frame, and a spacer sequence is contained between the two, and the spacer sequence can make the HNH nuclease coding frame and the ATPase coding frame express independently. 5.一种HNH毒性蛋白表达纯化方法,所述方法包含以下步骤:5. A method for expressing and purifying a HNH toxic protein, the method comprising the following steps: 1)将HNH核酸酶编码框、ATPase编码框在同一细胞内同时独立表达。1) The HNH nuclease coding frame and ATPase coding frame are expressed independently and simultaneously in the same cell. 2)表达产物初步纯化。2) Preliminary purification of the expression product. 3)初步纯化产物进行进一步纯化。3) The preliminary purified product is further purified. 6.根据权利要求5所述的HNH毒性蛋白表达纯化方法,其特征在于,步骤1)中HNH核酸酶编码框、ATPase编码框在同一个载体中同时独立表达。6. The method for expressing and purifying HNH toxic protein according to claim 5, characterized in that in step 1), the HNH nuclease coding frame and the ATPase coding frame are independently expressed simultaneously in the same vector. 7.根据权利要求5所述的HNH毒性蛋白表达纯化方法,其特征在于,步骤1)中所述ATPase编码框和HNH编码框均为来自大肠杆菌Retron-Eco4系统的ATPase核酸酶编码框和HNH编码框。7. The method for expressing and purifying HNH toxic protein according to claim 5, characterized in that the ATPase coding frame and the HNH coding frame in step 1) are both ATPase nuclease coding frame and HNH coding frame from the Escherichia coli Retron-Eco4 system. 8.根据权利要求5所述的HNH毒性蛋白表达纯化方法,其特征在于,步骤1)中所述ATPase编码框连接一个标签蛋白编码框,所述标签蛋白编码框与ATPase编码框一起表达出含有标签蛋白和ATPase的融合蛋白。8. The method for expressing and purifying HNH toxic protein according to claim 5, characterized in that the ATPase coding frame in step 1) is connected to a tag protein coding frame, and the tag protein coding frame and the ATPase coding frame together express a fusion protein containing the tag protein and ATPase. 9.一种内切酶,所述内核酸切酶的序列含有如序列SEQ ID NO.1所示的氨基酸序列。9. An endonuclease, the sequence of which contains the amino acid sequence shown in SEQ ID NO.1. 10.包含如SEQ ID NO.1所示的氨基酸序列的蛋白在制备内核酸切酶中的应用。10. Use of a protein comprising the amino acid sequence shown in SEQ ID NO. 1 in the preparation of an endonuclease.
CN202410524229.9A 2024-04-29 2024-04-29 Escherichia coli toxic protein and its use and prokaryotic expression method Pending CN118240856A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202410524229.9A CN118240856A (en) 2024-04-29 2024-04-29 Escherichia coli toxic protein and its use and prokaryotic expression method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202410524229.9A CN118240856A (en) 2024-04-29 2024-04-29 Escherichia coli toxic protein and its use and prokaryotic expression method

Publications (1)

Publication Number Publication Date
CN118240856A true CN118240856A (en) 2024-06-25

Family

ID=91560691

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202410524229.9A Pending CN118240856A (en) 2024-04-29 2024-04-29 Escherichia coli toxic protein and its use and prokaryotic expression method

Country Status (1)

Country Link
CN (1) CN118240856A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210130833A1 (en) * 2019-10-30 2021-05-06 The Broad Institute, Inc. Bacterial defense systems and methods of identifying thereof
CN117448368A (en) * 2023-11-03 2024-01-26 尚纯生物科技(武汉)有限公司 A method for preparing recombinant deoxyribonuclease by prokaryotic expression

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210130833A1 (en) * 2019-10-30 2021-05-06 The Broad Institute, Inc. Bacterial defense systems and methods of identifying thereof
CN117448368A (en) * 2023-11-03 2024-01-26 尚纯生物科技(武汉)有限公司 A method for preparing recombinant deoxyribonuclease by prokaryotic expression

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANSGAR J. POMMER ET AL.: "Mechanism and Cleavage Specificity of the H-N-H Endonuclease Colicin E9", 《JOURNAL OF MOLECULAR BIOLOGY》, vol. 314, no. 4, 31 December 2001 (2001-12-31), pages 735 - 749, XP004466209, DOI: 10.1006/jmbi.2001.5189 *
MILLMAN, A. ET AL.: "retron system putative HNH endonuclease [Escherichia coli]", 《GENBANK》, 12 June 2023 (2023-06-12), pages 1 *
NONE: "MULTISPECIES: retron Ec78 anti-phage system effector APTase PtuA [Enterobacteriaceae]", 《GENBANK》, 12 June 2023 (2023-06-12), pages 1 *
RIA WESTON ET AL.: "ZRANB3 is a structure-specific ATP-dependent endonuclease involved in replication stress response", 《GENES & DEVELOPMENT》, vol. 26, no. 14, 15 July 2012 (2012-07-15), pages 1558 - 1572 *

Similar Documents

Publication Publication Date Title
US11649443B2 (en) RNA-guided endonuclease fusion polypeptides and methods of use thereof
CN105238806B (en) A kind of building and its application of the CRISPR/Cas9 gene editing carrier for microorganism
JP6408914B2 (en) Modified CASCADE ribonucleoproteins and their uses
CN114410625A (en) RNA-guided DNA cleavage by the Cas9-crRNA complex
CN118726313A (en) CAS9 mutant gene of Streptococcus pyogenes and polypeptide encoded thereby
JPS58107184A (en) Stabilization of recombined dna containing host cell
JP2012531198A (en) Bacterial expression of artificial genes for production of CRM197 and its derivatives
CN113136374B (en) Preparation and application of recombinant mutant Tn5 transposase
WO2023138082A1 (en) Eukaryote-derived argonaute protein and use thereof
CA2939541C (en) Hybrid proteins and uses thereof
Chen et al. Functional characterization of an alkaline exonuclease and single strand annealing protein from the SXT genetic element of Vibrio cholerae
CN108148852B (en) A kind of alginate lyase SHA-6 gene and application
CN107475169A (en) Cas7 and Cas3 prokaryotic gene edit methods in a kind of type Cas systems based on I
CN118240856A (en) Escherichia coli toxic protein and its use and prokaryotic expression method
CN109486779B (en) DNA methyltransferase and soluble heterologous expression and separation and purification method thereof
CN112813088B (en) Preparation method of recombinant DpnI restriction enzyme
CN114230644A (en) GP32 protein mutant, recombinant vector, and construction method and application thereof
CN114645033A (en) Nucleoside triphosphate hydrolase and purification method and application thereof
WO2023019832A1 (en) Expression and purification method for main protease of coronavirus
CN111849939B (en) A nicked DNA-preferred high-fidelity polymerase and its application
CN107266540A (en) A kind of preparation method of mycobacterium tuberculosis elongation factors EF Tu albumen
CN105087554B (en) DNA phosphorothioate modifier clusters
KR101970471B1 (en) Vibrio cholerae strain that can be infected by CTX phages and can produce cholera toxin
CN116904420A (en) Mutant strains of Stoffel fragments with XNA recognition and synthesis activities and their applications
CN118006581A (en) Pfu DNA polymerase mutant strain with XNA recognition and synthesis activity and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination